Skip to main content
News Tag: news
NRG-GU011 (“NRG PROMETHEAN”) study of SABR with or without relugolix for PET-recurrent oligometastatic prostate cancer
Read More
NRG-GU009 ( “PREDICT-RT”) Parallel Phase III Randomized Trials For High Risk Prostate Cancer Evaluating De-Intensification For Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation
Read More
Testing the addition of trastuzumab or trastuzumab/pertuzumab to the usual chemotherapy for HER2 positive uterine serous or carcinosarcoma (NRG-GY026)
Read More
NRG Oncology accepting applications for the position of Vice Chair, Ancillary Projects Committee
Read More
NRG Oncology and The GOG Foundation Honor the Life of Mary “Dicey” Scroggins
Read More
NRG Oncology accepting applications for the position of Vice Chair, Radiation Oncology Committee
Read More
NRG Oncology Trial Aimed to Improve Prostate Cancer Survivor Care Planning Reaches Accrual Goal
Read More
Oncology Tube Conducts Interviews on NRG Oncology Research Presented During the 2022 ASCO Annual Meeting: NRG-HN002 and NRG-GI008
Read More
NRG Oncology NCORP Trial of Hippocampal Avoidance for Small Cell Lung Cancer Patients Receiving Prophylactic Cranial Irradiation Reaches Accrual Goal
Read More
NRG Oncology Appoints Several New Committee Chairs & Vice Chairs
Read More